Recommended

FDA tightens COVID vaccine use
Decentralised manufacturing consortium launched
Trial boost for myasthenia gravis drug
FDA starts publishing daily AE data
WEBINAR | The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology | 5 NOV
WEBINAR | Mastering Impurity Profiling: USP’s Evolving Standards and Strategies | 15 OCT
news

Dr Richard Torbett named as new ABPI Chief Executive

0
SHARES

The ABPI’s board has unanimously appointed Dr Richard Torbett as Chief Executive, commencing 1 January 2020.

Credit: The Association of the British Pharmaceutical Industry (ABPI).

Dr Richard Torbett has been announced as the new Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), from the beginning of 2020.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Torbett was unanimously selected by the ABPI Board as the new Chief Executive”

Torbett joined the ABPI in July 2015 and is currently Executive Director of Economic, Health and Commercial Policy. He takes over the role from Mike Thompson, who has served as Chief Executive since March 2016.

Torbett has spent the last 14 years working in senior roles across the pharmaceutical industry, both in the UK and internationally. His tenure includes Chief Economist at the European Federation of Pharmaceutical Industries and Associations (EFPIA) and Senior Director and Head of International Affairs at Pfizer.

ABPI President Haseeb Ahmad said, “Richard is a hugely respected figure within our industry both internationally and in the UK.

“We share an ambition to make the UK the best place in the world to research, develop and use new medicines and I look forward to working with him.”

Torbett was unanimously selected by the ABPI Board as the new Chief Executive following a competitive external recruitment process with an executive search agency.

He responded to the appointment saying, “I am proud to work for an industry that has such a profound effect on patients’ lives and I am hugely excited about taking up the role of Chief Executive of the ABPI.

“At this critical time for our country it’s vital that the world-leading UK life sciences industry continues to thrive. I look forward to working with all of our members and partners in Government and the NHS to achieve this.”

Share via
Share via